Celsius Therapeutics, Inc. announced it raised $48 Million in an amended filing from an offering of $65 Million

Oct 04, 2019•almost 6 years ago

Amount Raised

$48 Million

CambridgeHealthcare

Company Information

Company

Celsius Therapeutics, Inc.

Location

399 Binney Street

Cambridge, Maryland, United States

About

Celsius Therapeutics is a clinical-stage biotechnology company focused on developing novel medicines in inflammatory disease. Its lead therapeutic candidate is an anti-TREM1 antibody for the treatment of IBD. Celsius is dedicated to pioneering new therapies and is based in Cambridge, Mass.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Celsius Therapeutics, Inc. announced it raised $48 Million in an amended filing from an offering of $65 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Related People

Company Information